P08.60 RAMBO (rapid anti angiogenesis mediated by oncolytic virus) decreased bevacizumab-induced glioma cell invasion

INTRODUCTION: Anti-VEGF therapies such as bevacizumab have been shown to attenuate VEGF-mediated angiogenesis, to decrease vascular permeability, and to inhibit tumor growth in malignant glioma. Conversely, bevacizumab has also been reported to induce invasive proliferation. Oncolytic viral therapy...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Tomita, Y., Kurozumi, K., Shimizu, T., Oka, T., Otani, Y., Ishida, J., Fujii, K., Kaur, B., Tomotsugu, I., Date, I.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
POSTER PRESENTATIONS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464039/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.249
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items